Related Experiment Video
Updated: Jan 8, 2026

09:03
Field-Deployable Candidatus Liberibacter asiaticus Detection Using Recombinase Polymerase Amplification Combined with CRISPR-Cas12a
Published on: December 23, 2022
3.1K
Sensitivity-improving CRISPR-Cas strategies for non-nucleic acid targets detection
Huijuan Qi1, Yujin Yang1, Xiangting Hou1
1School of Chemistry and Chemical Engineering, Linyi University, Linyi 276005, China.
Methods (San Diego, Calif.)
|December 17, 2025
Summary
CRISPR-Cas systems offer powerful non-nucleic acid detection, but low enzyme turnover limits sensitivity. This review details strategies like amplification and labeling to boost CRISPR sensitivity for broader applications.
Area of Science:
- Biotechnology
- Molecular Biology
- Biosensing
Background:
- CRISPR-Cas systems are versatile tools for detecting non-nucleic acid targets.
- Low enzymatic turnover of Cas nucleases hinders the sensitivity of current CRISPR-based detection methods.
- Enhancing sensitivity is crucial for expanding the real-world applications of CRISPR technologies.
Purpose of the Study:
- To systematically review methodologies for enhancing the sensitivity of CRISPR-Cas systems in non-nucleic acid target detection.
- To elucidate the working mechanisms of CRISPR-Cas systems and signal transduction for non-nucleic acid targets.
- To discuss current challenges and future directions in the field.
Main Methods:
- Review of existing literature on CRISPR-Cas systems and sensitivity enhancement strategies.
- Analysis of signal transduction pathways for non-nucleic acid detection.
- Categorization of sensitivity-improving approaches, including amplification, labeling, and cascade methods.
Main Results:
- Identified key strategies to overcome low enzymatic turnover, including nucleic acid amplification, multimolecular labeling, dual-enzyme cascades, and multiplex amplification.
- Detailed the mechanisms underlying these sensitivity-enhancing approaches.
- Highlighted the importance of these strategies for achieving high-sensitive detection.
Conclusions:
- Significant progress has been made in enhancing CRISPR-Cas system sensitivity for non-nucleic acid detection.
- Further innovation is needed to address current challenges and realize the full potential of these technologies.
- The reviewed strategies provide a foundation for developing more sensitive and robust CRISPR-based diagnostic and detection tools.
Related Concept Videos
CRISPR/Cas9 Genome Editing
1.6K
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
1.6K
CRISPR
57.4K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
57.4K
CRISPR and crRNAs
18.7K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
18.7K
Homologous Recombination
62.4K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
62.4K

